ClinicalTrials.Veeva

Menu

Evaluate a Medication on How Hunger and Appetite Are Influenced by Smell

Pennington Biomedical Research Center logo

Pennington Biomedical Research Center

Status and phase

Terminated
Phase 1

Conditions

Food Intake

Treatments

Drug: Diltiazem
Other: Placebo spray

Study type

Interventional

Funder types

Other

Identifiers

NCT01021176
PBRC 27016

Details and patient eligibility

About

The purpose of this study is to determine whether the blood pressure medication, diltiazem, will temporarily decrease the sense of smell when given in a nasal spray which will then reduce food intake.

Full description

You will fast on your first visit. Complete questionnaire about taste and smell to insure you don't have a cold or anything that would interfere with sense of smell. Your nose will be checked. Blood pressure taken, and administer to you a spray with diltiazem 2, 4, 8 mg or a placebo. Your sense of smell will be tested at different time points.

Enrollment

12 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Body mass index (BMI) between 25 and 40 kg
  • Blood pressure in within normal range

Exclusion criteria

  • Used tobacco products in the past month
  • Used a calcium channel blocker medication in the last month
  • used nasal sprays in the last month
  • have an abnormal sense of smell or abnormalities of the lining in your nose
  • female and have irregular menstrual periods
  • female and are nursing a baby or pregnant
  • female and have had a partial hysterectomy (still have ovaries)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

12 participants in 4 patient groups, including a placebo group

0mg 0 spray
Placebo Comparator group
Description:
No Diltiazem
Treatment:
Other: Placebo spray
2mg 2 Spray
Active Comparator group
Description:
Staff member will administer an atomizer (device that changes a liquid into a fine spray) that will go into both nostrils. The atomizer will contain diltiazem, RxC Use 2mg/2 spray Diltiazem
Treatment:
Drug: Diltiazem
4mg 4 Spray
Active Comparator group
Description:
Staff member will administer an atomizer (device that changes a liquid into a fine spray) that will go into both nostrils. The atomizer will contain diltiazem, RxC Use 4mg/4 spray Diltiazem
Treatment:
Drug: Diltiazem
8mg 8 spray
Active Comparator group
Description:
Staff member will administer an atomizer (device that changes a liquid into a fine spray) that will go into both nostrils. The atomizer will contain diltiazem, RxC Use 8mg/8 spray Diltiazem
Treatment:
Drug: Diltiazem

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems